This is an external website. DAIC is not responsible for any content on the third party website.
September 2, 2015 — An investigational material known as Bioabsorbable Cardiac Matrix (BCM), designed to prevent cardiac ...
January 16, 2015 — Bellerophon Therapeutics LLC said it completed enrollment of its PRESERVATION I clinical trial of ...